Prasugrel
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06209 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | pulmonary hypertension | KG + DL |
| 2 | migraine disorder | KG + DL |
| 3 | migraine with brainstem aura | KG + DL |
| 4 | kyphoscoliotic heart disease | KG + DL |
| 5 | rheumatoid arthritis | KG + DL |
| 6 | homozygous familial hypercholesterolemia | KG + DL |
| 7 | hypoalphalipoproteinemia | KG + DL |
| 8 | migraine with or without aura, susceptibility to | KG + DL |
| 9 | brachydactyly-syndactyly syndrome | KG + DL |
| 10 | leprosy | KG + DL |
| 11 | atrophoderma vermiculata | KG + DL |
| 12 | peripheral vascular disease | KG + DL |
| 13 | hypertrichosis (disease) | KG + DL |
| 14 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 15 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 16 | Prinzmetal angina | KG + DL |
| 17 | peripheral arterial disease | KG + DL |
| 18 | obsolete familial combined hyperlipidemia | KG + DL |
| 19 | ulerythema ophryogenesis | KG + DL |
| 20 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 21 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 22 | myelodysplastic syndrome | KG + DL |
| 23 | gout | KG + DL |
| 24 | tendinitis | KG + DL |
| 25 | intermittent vascular claudication | KG + DL |
| 26 | fibromyalgia | KG + DL |
| 27 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 28 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 29 | headache disorder | KG + DL |
| 30 | coxopodopatellar syndrome | KG + DL |
| 31 | myositis fibrosa | KG + DL |
| 32 | idiopathic granulomatous myositis | KG + DL |
| 33 | unclassified myelodysplastic syndrome | KG + DL |
| 34 | familial clubfoot due to 17q23.1q23.2 microduplication | KG + DL |
| 35 | chromosome 17q23.1-q23.2 deletion syndrome | KG + DL |
| 36 | partial deletion of the long arm of chromosome 5 | KG + DL |
| 37 | refractory cytopenia of childhood | KG + DL |
| 38 | aregenerative anemia | KG + DL |
| 39 | isolated genetic hair shaft abnormality | KG + DL |
| 40 | female breast carcinoma | KG + DL |
| 41 | idiopathic pulmonary arterial hypertension | KG + DL |
| 42 | idiopathic and/or familial pulmonary arterial hypertension | KG + DL |
| 43 | severe congenital hypochromic anemia with ringed sideroblasts | KG + DL |
| 44 | cor pulmonale | KG + DL |
| 45 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 46 | heritable pulmonary arterial hypertension | KG + DL |
| 47 | trigeminal autonomic cephalalgia | KG + DL |
| 48 | intracranial arteriosclerosis | KG + DL |
| 49 | pulmonary hypertension, primary | KG + DL |
| 50 | inclusion body myositis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.